CN103058903B - Synthesis method for allicin derivative - Google Patents

Synthesis method for allicin derivative Download PDF

Info

Publication number
CN103058903B
CN103058903B CN201110324112.9A CN201110324112A CN103058903B CN 103058903 B CN103058903 B CN 103058903B CN 201110324112 A CN201110324112 A CN 201110324112A CN 103058903 B CN103058903 B CN 103058903B
Authority
CN
China
Prior art keywords
garlicin
synthetic method
analog derivative
hydrogen peroxide
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201110324112.9A
Other languages
Chinese (zh)
Other versions
CN103058903A (en
Inventor
姜标
张琛
李金华
陈思远
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Laishen Biotechnology Co., Ltd
Original Assignee
Shanghai Institute of Organic Chemistry of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Organic Chemistry of CAS filed Critical Shanghai Institute of Organic Chemistry of CAS
Priority to CN201110324112.9A priority Critical patent/CN103058903B/en
Publication of CN103058903A publication Critical patent/CN103058903A/en
Application granted granted Critical
Publication of CN103058903B publication Critical patent/CN103058903B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)

Abstract

The invention discloses a synthesis method for an allicin derivative. The allicin derivative has the structural general formula as the specification. The synthesis method comprises the following step of enabling R1-S-S-R2 as a raw material to react with hydrogen peroxide in a solvent by taking proline as a catalyst, wherein R1 and R2 are same or different and are C1-C4 alkanes or C2-C4 alkylenes. The synthesis method disclosed by the invention has the advantages of mild reaction condition, simplicity and convenience in operation, higher reaction yield, cleanness, environment friendliness and the like, meets the requirement of industrial production, and provides feasibility for wide popularization and application of the allicin derivative.

Description

A kind of synthetic method of garlicin analog derivative
Technical field
The synthetic method that the present invention relates to garlicin analog derivative, belongs to technical field of organic synthesis.
Background technology
Garlic (Alliiridum) is the traditional food and medicament dual-purpose plant of China, and garlicin is from garlic bulb, to extract the separated effective constituent obtaining, and structural formula is CH 2=CH-CH 2-S-S-S-CH 2-CH=CH 2, chemical name is Diallytrisin.Scientific research result shows, garlicin has many-sided medical treatment and health-care effect, it has inhibition and killing action in various degree to the pathogenic micro-organisms such as various bacteria, virus, fungi and tumour etc., in addition, it also have hypotensive, reducing blood-fat, hypoglycemic, improve immunity of organisms and the pharmacologically active such as anti-oxidant.At present, garlicin is used mainly as antibacterials clinically, has the reputation of natural Broad spectrum antibiotics, is applicable to bacterium and infects and deep fungal infection.But there is the shortcomings such as the strong and poor stability of pungency in garlicin, it is applied and be very limited.
At present, Chinese scholars mainly reduces the pungency of garlicin by physical methods such as entrapping method, microwave ultrasound methods, but these methods can not tackle the problem at its root, and likely reduces the pharmacologically active of garlicin.Wherein, the cyclodextrin encapsulated method of D mono-is to generally acknowledge good method, but also has the problems such as encapsulation rate is not high, effect is undesirable, cost is higher.Research shows: the garlicin analog derivative with following general structure
not only stable in properties, free from extraneous odour, and sterilization effect is good, can fundamentally solve the shortcomings (J.Am.Chem.Soc., 1947,69,1710~1713.) such as the strong and poor stability of pungency that garlicin exists.But, in prior art about preparation method's existence condition of above-mentioned garlicin analog derivative is harsh, reagent is expensive, complex steps, series of problems (J.Am.Chem.Soc., 1949 such as yield is low and environmental pollution is large, 71,3565~3566 and J.Am.Chem.Soc., 1997,119,9309~9310 and J.Org.Chem., 1978,43 (13), 2728~2730), be not suitable for suitability for industrialized production, so that affected the wide popularization and application of this analog derivative.
Summary of the invention
For the existing the problems referred to above of prior art and defect, the invention provides that a kind of preparation condition is gentle, yield is higher, simple to operate and the synthetic method of the above-mentioned garlicin analog derivative of clean environment firendly.
For achieving the above object, the technical solution used in the present invention is as follows:
A synthetic method for garlicin analog derivative, described garlicin analog derivative has following general structure:
its synthetic method comprise the steps: with for raw material, proline(Pro) is catalyzer, in solvent with hydroperoxidation; Wherein: R 1with R 2identical or different, be C 1-C 4alkyl or C 2-C 4alkylene.
The synthetic method of described garlicin analog derivative, can also comprise the steps: with for raw material, proline(Pro) is catalyzer, under oxygenant effect, in solvent with hydroperoxidation; Wherein: R 1with R 2identical or different, be C 1-C 4alkyl or C 2-C 4alkylene.
Described R 1with R 2be preferably identically, and be all preferably methyl, ethyl, propyl group, butyl, sec.-propyl or allyl group.
Described be recommended as 1: 1 with the mol ratio of hydrogen peroxide~1: 5; Be preferably 1: 1~1: 3.
Described temperature of reaction is recommended as 0~60 ℃; Be preferably 0~40 ℃.
Described solvent is recommended as water, ethyl acetate, tetrahydrofuran (THF), methyltetrahydrofuran, t-butyl methyl ether, acetonitrile, methylene dichloride or 1,2-ethylene dichloride; Be preferably water, t-butyl methyl ether, acetonitrile or 1,2-ethylene dichloride.
Described oxygenant is recommended as the vitriol oil, concentrated nitric acid, chlorine, clorox, peroxy tert-butyl alcohol or metachloroperbenzoic acid; Be preferably concentrated nitric acid, chlorine, peroxy tert-butyl alcohol or metachloroperbenzoic acid.
Described oxygenant and the mol ratio of hydrogen peroxide be recommended as 0.1: 1~and 0.8: 1; Be preferably 0.2: 1~0.5: 1.
Compared with prior art, synthetic method of the present invention has reaction conditions gentleness, easy and simple to handle, reaction yield is higher and the advantage such as clean environment firendly, is applicable to industrialization production requirements, for the wide popularization and application of described garlicin analog derivative provides feasibility.
Embodiment
Below in conjunction with embodiment, the present invention is described in further detail and completely.
Embodiment 1: methyl sulfo--sulfinic acid methyl esters preparation
Methyl disulfide (20g) and L-PROLINE (2g) are dissolved in acetonitrile (10ml), at 0 ℃, drip wherein hydrogen peroxide (30%, 40g); Stir, be naturally warmed up to 25 ℃, after question response is complete, at 20 ℃, acetonitrile is removed in decompression; Add dichloromethane extraction layering, collected organic layer, with after saturated common salt water washing, with anhydrous sodium sulfate drying; Concentrating under reduced pressure at 20 ℃, removes solvent, and the faint yellow oily product obtaining, is methyl sulfo--sulfinic acid methyl esters 18.7g, molar yield 80%, HPLC purity > 90%.
Embodiment 2: methyl thiosulfonic acid methyl esters preparation
Methyl disulfide (40g) and L-PROLINE (4g) are dissolved in methyltetrahydrofuran (10ml), at 10 ℃, drip wherein hydrogen peroxide (30%, 150g); Stir, be naturally warmed up to 30 ℃, after question response is complete, at 20 ℃, methyltetrahydrofuran is removed in decompression; Add dichloromethane extraction layering, collected organic layer, with after saturated common salt water washing, with anhydrous sodium sulfate drying; Concentrating under reduced pressure at 20 ℃, removes solvent, and the faint yellow oily product obtaining, is methyl thiosulfonic acid methyl esters 46g, molar yield 85%, HPLC purity > 90%.
Embodiment 3: ethylenebis dithiocarbamate-sulfinic acid ethyl ester preparation
Diethyl two sulphur (100g) and L-PROLINE (5g) are dissolved in 1,2-ethylene dichloride (40ml), at 10 ℃, drip wherein hydrogen peroxide (30%, 160g); Stir, be warmed up to 40 ℃, after question response is complete, add dichloromethane extraction layering, collected organic layer, with after saturated common salt water washing, with anhydrous sodium sulfate drying; Concentrating under reduced pressure at 20 ℃, removes solvent, and the faint yellow oily product obtaining, is ethylenebis dithiocarbamate-sulfinic acid ethyl ester 90g, molar yield 80%, HPLC purity > 90%.
Embodiment 4: O-Ethyl ethanesulfonothioate preparation
Diethyl two sulphur (10g) and L-PROLINE (1g) are dissolved in methyl tertiary butyl ether (10ml), at 10 ℃, drip wherein hydrogen peroxide (30%, 22g); Under stirring, add peroxy tert-butyl alcohol (6g) again, be slowly warmed up to 60 ℃, after question response is complete, at 20 ℃, concentrating under reduced pressure is removed solvent; Add dichloromethane extraction layering, collected organic layer, with after saturated common salt water washing, with anhydrous sodium sulfate drying; At 20 ℃, concentrating under reduced pressure is removed solvent, and the faint yellow oily product obtaining, is O-Ethyl ethanesulfonothioate 10g, molar yield 78%, HPLC purity > 90%.
Embodiment 5: isopropylthio-sulfinic acid isopropyl ester preparation
Sec.-propyl two sulphur (50g) and L-PROLINE (1g) are dissolved in ethyl acetate (15ml), at 10 ℃, drip wherein hydrogen peroxide (30%, 76g); Stir, be warmed up to 40 ℃, after question response is complete, add dichloromethane extraction layering, collected organic layer, with after saturated common salt water washing, with anhydrous sodium sulfate drying; At 20 ℃, concentrating under reduced pressure is removed solvent, and the faint yellow oily product obtaining, is isopropylthio-sulfinic acid isopropyl ester 45g, molar yield 82%, HPLC purity > 90%.
Embodiment 6: isopropylthio sulfonic acid isopropyl ester preparation
Sec.-propyl two sulphur (50g) and L-PROLINE (1g) are dissolved in acetonitrile (15ml), at 10 ℃, drip wherein hydrogen peroxide (30%, 160g); Under stirring, add concentrated nitric acid (9g) again, be slowly warmed up to 50 ℃, after question response is complete, at 20 ℃, concentrating under reduced pressure is removed solvent; Add dichloromethane extraction layering, collected organic layer, with after saturated common salt water washing, with anhydrous sodium sulfate drying; At 20 ℃, concentrating under reduced pressure is removed solvent, and the faint yellow oily product obtaining, is isopropylthio sulfonic acid isopropyl ester 47g, molar yield 78%, HPLC purity > 90%.
Embodiment 7: allyl group thiosulfonic acid allyl ester preparation
By in diallyl disulfide (10g) and L-PROLINE (1g) water-soluble (10ml), at 10 ℃, drip wherein hydrogen peroxide (30%, 22g), stir, be warmed up to 50 ℃, after question response is complete, add dichloromethane extraction layering, collected organic layer, with after saturated common salt water washing, with anhydrous sodium sulfate drying; Concentrating under reduced pressure at 20 ℃, removes solvent, and the faint yellow oily product obtaining, is allyl group thiosulfonic acid allyl ester 10g, molar yield 82%, HPLC purity > 90%.
Embodiment 8: allyl sulfide is for-sulfinic acid allyl ester preparation
Diallyl disulfide (10g) and L-PROLINE (1g) are dissolved in methyltetrahydrofuran (10ml), at 20 ℃, drip wherein hydrogen peroxide (30%, 10g), stir, be warmed up to 40 ℃, after question response is complete, add dichloromethane extraction layering, collected organic layer, with after saturated common salt water washing, with anhydrous sodium sulfate drying; At 20 ℃, concentrating under reduced pressure is removed solvent, obtains faint yellow oily product product, is allyl sulfide for-sulfinic acid allyl ester 9g, molar yield 80%, HPLC purity > 90%.
Embodiment 9: methyl sulfo--sulfinic acid allyl ester preparation
Methacrylic two sulphur (20g) and L-PROLINE (1g) are dissolved in 1,2-ethylene dichloride (10ml), at 10 ℃, drip wherein hydrogen peroxide (30%, 43g); Stir, be warmed up to 40 ℃, after question response is complete, add dichloromethane extraction layering, collected organic layer, with after saturated common salt water washing, with anhydrous sodium sulfate drying; At 20 ℃, concentrating under reduced pressure is removed solvent, and the faint yellow oily product obtaining, is methyl sulfo--sulfinic acid allyl ester 19g, molar yield 85%, HPLC purity > 90%.
Embodiment 10: methyl thiosulfonic acid ethyl ester preparation
Methylethyl two sulphur (20g) and L-PROLINE (1g) are dissolved in acetonitrile (10ml), at 10 ℃, drip wherein hydrogen peroxide (30%, 86g); Under stirring, add clorox (46g) again, be slowly warmed up to 60 ℃, after question response is complete, at 20 ℃, concentrating under reduced pressure is removed solvent; Add dichloromethane extraction layering, collected organic layer, with after saturated common salt water washing, with anhydrous sodium sulfate drying; Concentrating under reduced pressure at 20 ℃, removes solvent, and the faint yellow oily product obtaining, is methyl thiosulfonic acid ethyl ester 19g, molar yield 75%, HPLC purity > 90%.
In sum, adopt that the synthetic garlicin analog derivative of the inventive method has reaction conditions gentleness, easy and simple to handle, reaction yield is higher and the advantage such as clean environment firendly, be applicable to industrialization production requirements.
Be necessary to be pointed out that at this: above-described embodiment is only used to further illustrate the present invention; can not be interpreted as limiting the scope of the invention, some nonessential improvement that those skilled in the art's foregoing according to the present invention is made and adjustment all belong to protection scope of the present invention.

Claims (6)

1. a synthetic method for garlicin analog derivative, described garlicin analog derivative has following general structure:
it is characterized in that, described synthetic method comprise the steps: with for raw material, proline(Pro) is catalyzer, under oxygenant effect, in solvent with hydroperoxidation; Wherein: R 1with R 2difference, described R 1for methyl, R 2for ethyl or allyl group;
Described with the mol ratio of hydrogen peroxide be 1:1~1:5;
Described oxygenant and the mol ratio of hydrogen peroxide are 0.1:1~0.8:1;
Described temperature of reaction is 0~60 ℃;
Described solvent is water, ethyl acetate, tetrahydrofuran (THF), methyltetrahydrofuran, t-butyl methyl ether, acetonitrile, methylene dichloride or 1,2-ethylene dichloride;
Described oxygenant is the vitriol oil, concentrated nitric acid, chlorine, clorox, peroxy tert-butyl alcohol or metachloroperbenzoic acid.
2. the synthetic method of garlicin analog derivative according to claim 1, is characterized in that: described with the mol ratio of hydrogen peroxide be 1:1~1:3.
3. the synthetic method of garlicin analog derivative according to claim 1, is characterized in that: described temperature of reaction is 0~40 ℃.
4. the synthetic method of garlicin analog derivative according to claim 1, is characterized in that: described solvent is water, t-butyl methyl ether, acetonitrile or 1,2-ethylene dichloride.
5. the synthetic method of garlicin analog derivative according to claim 1, is characterized in that: described oxygenant is concentrated nitric acid, chlorine, peroxy tert-butyl alcohol or metachloroperbenzoic acid.
6. the synthetic method of garlicin analog derivative according to claim 1, is characterized in that: described oxygenant and the mol ratio of hydrogen peroxide are 0.2:1~0.5:1.
CN201110324112.9A 2011-10-21 2011-10-21 Synthesis method for allicin derivative Active CN103058903B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110324112.9A CN103058903B (en) 2011-10-21 2011-10-21 Synthesis method for allicin derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110324112.9A CN103058903B (en) 2011-10-21 2011-10-21 Synthesis method for allicin derivative

Publications (2)

Publication Number Publication Date
CN103058903A CN103058903A (en) 2013-04-24
CN103058903B true CN103058903B (en) 2014-11-05

Family

ID=48101837

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110324112.9A Active CN103058903B (en) 2011-10-21 2011-10-21 Synthesis method for allicin derivative

Country Status (1)

Country Link
CN (1) CN103058903B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992578A (en) * 1990-03-09 1991-02-12 Atochem North America, Inc. Preparation of alkyl alkanethiolsulfonates
AU2002235749A1 (en) * 2000-12-15 2002-06-24 Bayer Aktiengesellschaft Thiosulphonic s-esters as material protective agent
CN102807517A (en) * 2011-06-02 2012-12-05 上海科材生物科技有限公司 Synthesis of garlicin derivatives and preparation method for medical ultrasonic couplant with efficient disinfection function using garlicin derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
K.Rajender Reddy等.L-Proline-H2O2:A New Chemoselective Approach for Oxidation of Sulfides to Sulfoxides.《Synthetic Communications》.2006,第36卷 *

Also Published As

Publication number Publication date
CN103058903A (en) 2013-04-24

Similar Documents

Publication Publication Date Title
CN102702220B (en) Method for extracting arteannuic acid from artemisinin crystallization mother liquor
CN101962374A (en) Preparation method of butylphthalide
CN110627690A (en) Novel p-coumaric acid sulfonate derivative and preparation method and application thereof
CN102320953B (en) Method for preparing natural alpha-linolenic acid from crude oil of idesia polycarpa var.vestita diels
NZ577081A (en) Synthesis of compounds useful as modulators of amyloid-beta production
CN103058903B (en) Synthesis method for allicin derivative
CN109456182B (en) Synthesis of (5Z,7E) -dodeca-5, 7-dien-1-ol and its acetate and propionate
CN103073462A (en) Preparation method of dithiothreitol
CN104844431B (en) 1-(2,6,6-trimethyl-cyclohexenyl)-2-buten-1-one preparation method
CN105883895A (en) Preparation method of copper iodide
CN103214534A (en) Preparation method of 3'-desoxyadenossine
CN107936080B (en) Method for extracting ursolic acid in cynomorium songaricum by using eutectic solvent/salt aqueous two-phase system
CN102153462A (en) Method for synthesizing tanshinol
CN102924540B (en) A kind of preparation method of 2-deoxy-D-glucose
CN102249962B (en) Preparation method of 1,1-disulfur-1-olefin
CN104130206B (en) The synthetic method of 2-butyl-1,2-benzisothiazole-3-ketone
CN108440460B (en) Preparation method of perillene and analogues thereof
CN104844452B (en) Method for synthesizing female tomato moth pheromone
CN103420804A (en) Method for preparing high-purity hydroxytyrosol
CN102702135B (en) Benzoyl thiourea compound with benzothiazole structure and preparation method and application of compound
CN105693658A (en) Stearolactone synthesis process
CN105198834B (en) The synthesis technique of 2,6 dibromo benzothiazoles
CN105061205B (en) Synthesis method of Z9,11-dodecadienol acetate
CN108142829A (en) A kind of production method of malt selenium
CN101376640A (en) Low irritation garlicin derivative, and synthetic method and use thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20211116

Address after: 201605 Building 2, No. 309, Haohai Road, Xinbang Town, Songjiang District, Shanghai

Patentee after: Shanghai Laishen Biotechnology Co., Ltd

Address before: 200032 No. 354, Fenglin Road, Xuhui District, Shanghai

Patentee before: Shanghai Institute of organic chemistry, Chinese Academy of Sciences